Academic Radiology
Volume 17, Issue 3 , Pages 333-339 , March 2010

The Mammographic Correlations with Basal-Like Phenotype of Invasive Breast Cancer

  • Xiao Wang, MD, PhD

      Affiliations

    • Department of Breast Surgery, Jinan Central Hospital, Shandong University School of Medicine, Jinan 250013, China
    • Corresponding Author InformationAddress correspondence to: X.W.
    • ,
  • Lan Chao, MD, PhD

      Affiliations

    • Infertility Center, Qilu Hospital, Shandong University, Jinan, China
    • ,
  • Liansheng Chen, MD

      Affiliations

    • Department of Breast Surgery, Jinan Central Hospital, Shandong University School of Medicine, Jinan 250013, China
    • ,
  • Guohui Ma, MD

      Affiliations

    • Department of Breast Surgery, Jinan Central Hospital, Shandong University School of Medicine, Jinan 250013, China
    • ,
  • Guangchao Jin, MD

      Affiliations

    • Department of Breast Surgery, Jinan Central Hospital, Shandong University School of Medicine, Jinan 250013, China
    • ,
  • Mei Hua, MD

      Affiliations

    • Department of Radiology, Jinan Central Hospital, Shandong University School of Medicine, Jinan 250013, China
    • ,
  • Gengyin Zhou, MD

      Affiliations

    • Department of Pathology, Shandong University School of Medicine, Jinan 250013, China

Received 27 August 2009 ,Accepted 1 October 2009.

References 

  1. Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100:8418–8423
  2. Livasy CA, Karaca G, Nanda R, et al. Phenotype evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol. 2006;19:264–271
  3. Karamouzis MV, Likaki-Karatza E, Ravazoula P, et al. Non-palpable breast carcinomas: correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors. Int J Cancer. 2002;102:86–90
  4. Evans AJ, Pinder SE, Ellis IO, et al. Correlations between the mammographic features of ductal carcinoma in situ (DCIS) and C-erbB-2 oncogene expression. Clin Radiol. 1994;49:559–562
  5. Seo BK, Pisano ED, Kuzimak CM, et al. Correlation of HER-2/neu overexpression with mammography and age distribution in primary breast carcinomas. Acad Radiol. 2006;13:1211–1218
  6. Wang X, Chao L, Chen L, et al. Correlation of mammographic calcifications with HER-2/neu overexpression in primary breast carcinomas. J Digit Imaging. 2008;21:170–176
  7. Likaki-Karatza E, Ravazoula P, Androutsopoulos G, et al. Correlation of mammographic appearance and molecular prognostic factors in high-grade breast carcinomas. Eur J Gynaecol Oncol. 2006;27:39–41
  8. Ildefonso C, Vazquez J, Guinea O, et al. The mammographic appearance of breast carcinomas of invasive ductal type: relationship with clinicopathological parameters, biological features and prognosis. Eur J Obstet Gynecol Reprod Biol. 2008;136:224–231
  9. Luck AA, Evans AJ, James JJ, et al. Breast carcinoma with basal phenotype: mammographic findings. AJR Am J Roentgenol. 2008;191:346–351
  10. Yang WT, Dryden M, Broglio K, et al. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat. 2008;111:405–410
  11. Le Doussal V, Tubiana-Hulin M, Friedman S, et al. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR): an improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer. 1989;64:1914–1921
  12. Greene FI, Page DI, Fleming ID. AJCC cancer staging manual. 6th ed.. New York: Springer; 2002;
  13. Obenauer S, Hermann KP, Grabbe E. Applications and literature review of the BI-RADS classification. Eur Radiol. 2005;15:1027–1036
  14. American College of Radiology. Breast imaging reporting and data system (BI-RADS). 4th ed.. Reston, VA: American College of Radiology; 2003;
  15. Cheang MC, Voduc D, Bajdik C, et al. Basal-like breast cancer defined by 5 biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res. 2008;14:1368–1376
  16. Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004;10:5367–5374
  17. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492–2502
  18. Bertucci F, Finetti P, Cervera N, et al. How basal are triple-negative breast cancers?. Int J Cancer. 2008;123:236–240
  19. Bidard FC, Conforti R, Boulet T, et al. Does triple negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 ‘triple-negative’ breast cancers. Ann Oncol. 2007;18:1285–1286
  20. Tan DS, Marchio C, Jones RL, et al. Triple negative breast cancer molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. Breast Cancer Res Treat. 2008;111:27–44
  21. Bauer KR, Brown M, Cress RD, et al. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer. 2007;109:1721–1728
  22. Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13:4429–4434
  23. Brown M, Tsodikov A, Bauer KR, et al. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999–2004. Cancer. 2008;112:737–747
  24. Lund MJ, Butler EN, Bumpers HL, et al. High prevalence of triple-negative tumors in an urban cancer center. Cancer. 2008;113:608–615
  25. Rakha EA, El-Rehim DA, Paish C, et al. Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance. Eur J Cancer. 2006;42:3149–3156
  26. Tabar L, Chen H-H, Duffy SW, et al. A novel method for prediction of long-term outcome of women with T1a, T1b, and 10–14 mm invasive breast cancers: a prospective study. Lancet. 2000;355:429–433
  27. Thurfjell E, Thurfjell MG, Lindgren A. Mammographic finding as predictor of survival in 1–9 mm invasive breast cancers. Worse prognosis for cases presenting as calcifications alone. Breast Cancer Res Treat. 2001;67:177–180
  28. Broeders MM, Onland-Moret NC, Rijken HM, et al. Use of previous screening mammograms to identify features indicating cases that would have a possible gain in prognosis following earlier detection. Eur J Cancer. 2003;39:1770–1775
  29. Yankaskas BC, Schell MJ, Bird RE, et al. Reassessment of breast cancers missed during routine screening mammography: a community-based study. Am J Roentgenol. 2001;177:535–541
  30. Venkatesan A, Chu P, Kerlikowske K, et al. Positive predictive value of specific mammographic findings according to reader and patient variables. Radiology. 2009;250:648–657

PII: S1076-6332(09)00583-2

doi: 10.1016/j.acra.2009.10.011

Academic Radiology
Volume 17, Issue 3 , Pages 333-339 , March 2010

Article Tools

* Image Usage & Resolution